Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).
Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M, Hassan AH, Leon MB, Moses JW, Popma JJ, Bonneau HN, Yock PG, Fitzgerald PJ, Honda Y; SIRIUS Trial Investigators. Sakurai R, et al. Among authors: popma jj. Am J Cardiol. 2005 Nov 1;96(9):1251-3. doi: 10.1016/j.amjcard.2005.06.066. Epub 2005 Sep 6. Am J Cardiol. 2005. PMID: 16253592
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
Holmes DR Jr, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, King SB 3rd, Lincoff AM, Tcheng JE, Chan R, Granett JR, Poland M. Holmes DR Jr, et al. Among authors: popma j. Circulation. 2002 Sep 3;106(10):1243-50. doi: 10.1161/01.cir.0000028335.31300.da. Circulation. 2002. PMID: 12208800 Free article. Clinical Trial.
Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy.
Casserly IP, Aronow HD, Schoenhagen P, Tsutsui H, Popovich J, Goormastic M, Popma JJ, Nissen SE, Tuzcu EM. Casserly IP, et al. Among authors: popma jj. J Am Coll Cardiol. 2002 Nov 6;40(9):1573-8. doi: 10.1016/s0735-1097(02)02341-0. J Am Coll Cardiol. 2002. PMID: 12427408 Free article.
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.
Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC. Kereiakes DJ, et al. Circulation. 2003 Sep 16;108(11):1310-5. doi: 10.1161/01.CIR.0000087602.91755.19. Epub 2003 Aug 25. Circulation. 2003. PMID: 12939212 Clinical Trial.
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Holmes DR Jr, et al. Among authors: popma jj. Circulation. 2004 Feb 10;109(5):634-40. doi: 10.1161/01.CIR.0000112572.57794.22. Circulation. 2004. PMID: 14769686 Clinical Trial.
577 results